On February 26, Bharat Biotech Ltd had said it signed an agreement with the Brazilian government for the supply of 20 million doses of Covaxin during the second and third quarters of 2021
Bharat Biotech Says It Has Scaled up Covaxin Production to 700 Million Doses Annually
PTI has reported the company had 200 million doses capacity when it started producing Covaxin in the beginning.
In this illustrative photograph, vials labelled âCovaxinâ rest on a table. Photo: Reuters
Health6 hours ago
Hyderabad: Bharat Biotech on Tuesday said it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per annum.
According to a press release issued by the city-based vaccine maker, manufacturing scale up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.
Sources said the company had 200 million doses capacity when it started producing Covaxin in the beginning.
Bharat Biotech to supply Covaxin to Brazil, inks deal with Precisa Medicamentos
The Government of Brazil will procure Covaxin directly from Bharat Biotech while supply to the private market will be subjected to authorisation from Brazilian regulatory authority ANVISA.
advertisement
UPDATED: January 12, 2021 18:27 IST
64 envoys from various countries visiting Bharat Biotech s facility in Hyderabad on December 9 (Photo Credits: PTI)
Bharat Biotech Tuesday signed an agreement with Precisa Medicamentos to supply its Covid-19 vaccine Covaxin to Brazil. Earlier, a team from Precisa Medicamentos visited the Bharat Biotech facility ahead of discussing potential export possibilities of India s first indigenous vaccine for cororonavirus.
According to a press release by the Hyderabad-based pharma company, the team met Bharat Biotech chief Dr Krishna Ella on January 7 and January 8 at its facility in Hyderabad s Genome Valley. Ambassador of Brazil to India, André Aranha Corrêa do Lago al